Antisense oligonucleotide of hypoxia-inducible factor-1alpha suppresses growth and tumorigenicity of lung cancer cells A549

Abstract

To study the role and mechanisms of hypoxia-inducible factor-1alpha (HIF-1α) on the growth and tumorigenicity of lung cancer cells A549, the antisense oligonucleotide of HIF-1α was transfected to A549 cells. The effect of the antisense oligonucleotide on tumor growth in vitro and in vivo was evaluated by the growth rate suppression of A549 cells and subcutaneous implanted tumor in nude mice, and the effect on tumorigenicity was evaluated by the expression inhibition of angiogenic factors, the microvessel density (MVD) and vascular endothelial growth factor (VEGF) protein expression which were detected by immohistochemistry and western blot respectively. This study revealed that in vitro the growth rate of antisense oligonucleotide group was significantly decreased as compared with that of control group, sense oligonucleotide group and false-sense oligonucleotide group; in vivo the weight of implanted tumors in nude mice of antisense oligonucleotide group was 1.51±0.40 g, which was significantly lower than that of control group (2.79±0.33 g), sense oligonucleotide group (2.81±0.45g) and false-sense oligonucleotide group (2.89±0.39 g) and the inhibitory rate was 47 %. Both MVD and VEGF protein expression were significantly inhibited in antisense oligonucleotide group compared with those in other groups. These results indicated that antisense oligonucleotide of HIF-1α could inhibit lung cancer cells A549 growth in vitro and in vivo, and the mechanism may be due to the inhibition of vascular growth and VEGF protein expression.

Keywords

hypoxia inducible factor-1alpha / antisense oligonucleotide / vascular endothelial growth factor

References

[1] WengerR. H., GassmannM.. Oxygen and the hypoxia-inducible factor-1. Biol Chem, 1997, 378(7): 609-616

[2] GraeberT.G., OsmanianC., JacksT., et al.. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature, 1996, 379(6560): 88-91

[3] DameronK. M., VolpertO. V., TainskyM.A., et al.. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science, 1994, 265(5178): 1582-1584

[4] MukhopadhyayD., TsiokasL., SukhatmeV. P.. Wild-type p53 and v-Src exert opposing influences on human vascular endothelial growth factor gene expression. Cancer Res, 1995, 55(24): 6161-6165

[5] IkedaE.. Cellular response to tissue hypoxia and its involvement in disease progression. Pathol Int, 2005, 55: 603-610

[6] BelozerovV. E., Van MeirE. G.. Hypoxia inducible factor-1: a novel target for cancer therapy. Anticancer Drugs, 2005, 16: 901-909

[7] GardnerL. B., LiQ., ParkM.S., et al.. Hypoxia inhibits G₁/S transition through regulation of p27 expression. J Biol Chem, 2001, 276(11): 7919-7926

[8] LiuJ. R., ChenB. Q., YangY.M., et al.. Effect of apoptosis on gastric adenocarcinoma cell line SGC-7901 induced by cis-9, trans-11-conjugated linoleic acid. World J Gastroenterol, 2002, 8(6): 999-1004

[9] MaxwellP. H., DachsG. U., GleadleJ. M., et al.. Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc Natl Acad Sci USA, 1997, 94(15): 8104-8109

[10] WeidnerN.. Tumor angiogenesis: review of current applications in tumor prognostication. Semin Diagn Pathol, 1993, 10(4): 302-313

[11] ZhongH., De MarzoA. M., LaughnerE., et al.. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res, 1999, 59(22): 5830-5835

[12] CarmelietP., DorY., HerbertJ. M., et al.. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature, 1998, 394(6692): 485-490

[13] RyanH. E., LoJ., JohnsonR. S.. HIF-1 alpha is required for solid tumor formation and embryonic vascularization. EMBO J, 1998, 17(11): 3005-3015